Back

Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: New insights into pharmacotherapy for acute heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Porntep Amornritvanich

Ramathibodi Hospital of Mahidol University, Bangkok (Thailand)

7 More presentations in this session

Presentation thumbnail
Spectrum of heart failure in 16 sub-saharan countries: drugs strategies and 8-year trends (the february study 2016-2023)
Professor I. Diop (Dakar, SN)
Abstract Slides Video
Presentation thumbnail
Combination of diuretics to overcome diuretic resistance in acute heart failure: systematic review and updated network meta-analysis
Doctor I. Girard Cunha Vieira Lima (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Effect of renin-angiotensin system inhibitors in elderly patients with heart failure and reduced ejection fraction
Doctor Y. Tamaki (Tenri, JP)
Abstract Slides Video
Presentation thumbnail
REDUCE-HF: a stronger heart go a long way
Doctor K. Kam (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Rationale and study design of the international randomized control trial MYocarditis THerapy with Steroids: the MYTHS trial
Doctor E. Ammirati (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New insights into pharmacotherapy for acute heart failure

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Real-world use of empaglifozin and dapaglifozin in patients with HEART failure
thumbnail
Congress Presentation
Pharmacological treatments in adults with chronic heart failure: a systematic review and component network meta-analysis
thumbnail
Congress Presentation
A real-world population with HFrEF treated with dapagliflozin or empagliflozin: a comparative analysis with DAPA-HF and EMPEROR REDUCED studies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources